Log In
BCIQ
Print this Print this
 

LTI-01

  Manage Alerts
Collapse Summary General Information
Company Lung Therapeutics Inc.
DescriptionSingle chain urokinase plasminogen activator
Molecular Target Plasminogen
Mechanism of ActionPlasminogen activator inhibitor-1 (PAI-1)
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard Indication Pulmonary (unspecified)
Indication DetailsTreat empyema; Treat fibrinous scar tissue in patients with loculated pleural effusion; Treat pleural effusion (PE)
Regulatory Designation U.S. - Orphan Drug (Treat empyema);
EU - Orphan Drug (Treat empyema)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today